Ultra Potent C 1000mg 30T
R255.00
Out of stock
Gentle, Buffered Vitamin C
Ultra Potent-C 1000 is an exclusive, patented formula with 1,000 mg of vitamin C per tablet and a high potency metabolite support system.
Description
Gentle, Buffered Vitamin C
Ultra Potent-C 1000 is an exclusive, patented formula with 1,000 mg of vitamin C per tablet and a high potency metabolite support system.
Features
° Scientifically shown to promote natural killer (NK) cell activity and white blood cell (WBC) function
° Shown to have 18% to 25% higher uptake in WBCs than plain vitamin C (ascorbic acid)
° Provides vitamin C and a metabolite system designed for enhanced utilization
° Prevents potential stomach upset associated with vitamin C by using buffering agents
Size: 30 tablets
Directions
Take one tablet up to two times daily or as directed.
Allergen Information
Free from: GMO and Gluten
Ingredients
Ingredients: Ultra Potent-C† (calcium ascorbate, niacinamide ascorbate, ascorbic acid, sodium ascorbate, magnesium ascorbate, L-lysine HCl, ascorbyl palmitate, citrus bioflavonoid complex, potassium ascorbate, tetrasodium pyrophosphate, alpha D-ribofuranose, L-cysteine HCl, xylitol, and L-glutathione), microcrystalline cellulose, cellulose, stearic acid (vegetable), croscarmellose sodium, magnesium stearate (vegetable), and coating (hypromellose, medium chain triglycerides , and hydroxypropylcellulose).
Nutrition Information
Serving size = 1 tablet
Number of servings: 30
Amount Per Serving | % Daily Value | |
Vitamin C | 1,000 mg | 1,667% |
Niacin | 70 mg | 350% |
Calcium | 43 mg | 4% |
Sodium | 12 mg | 1% |
Potassium | 5 mg | <1% |
L-Lysine | 33 mg | * |
Citrus Bioflavonoid Complex [standardized to 45% (14.4 mg) full spectrum bioflavonoids] | 32 mg | * |
Tetrasodium Pyrophosphate | 14 mg | * |
Alpha D-Ribofuranose | 13 mg | * |
Xylitol | 9 mg | * |
L-Cysteine | 8 mg | * |
L-Glutathione | 5 mg | * |
†Ultra Potent-C® U.S. Patent #5,626,883.
Brand
Brand
Metagenics
Reviews (0)
You must be logged in to post a review.
Reviews
There are no reviews yet.